PhRMA (@PhRMA) / X

PhRMA

16.9K posts

PhRMA

@PhRMA

Representing America’s biopharma & biotech companies. Shaping policy so science thrives & patients benefit.

Washington, DC

Joined February 2010

Pinned
PhRMA
@PhRMA
May 6
Today, we launched a new campaign to highlight how the 340B hospital markup program is a goldmine for big nonprofit hospital systems. With no rules or transparency, hospitals can spend on luxury perks while patients face higher bills. Washington needs to fix 340B!
00:00
New Ad Reveals Hospitals Hide How They Profit From 340B Markups
From phrma.org
2.1K
PhRMA
@PhRMA
Jun 10
Today, our researchers are heading to Capitol Hill to meet directly with lawmakers and congressional staff to advocate for the pro-innovation policies that ensure America stays a global leader in medical discovery. #PhRMAFlyIn26
384
PhRMA
@PhRMA
Jun 9
Our researchers are convening in DC today for #PhRMAFlyIn26! Tomorrow, they will go to Capitol Hill to advocate for the policies needed to deliver new treatments to patients. Follow along on Instagram >>> ow.ly/S0iF50Z9ubx
366
PhRMA
@PhRMA
Jun 9
Patients in other high-income countries have access to just 36% of new medicines. U.S. patients have access to 88%. That gap is driven by policy choices that delay or restrict access. We need policies that support innovation and ensure patients get the treatments they need.
Access to New Medicines
From phrma.org
3.1K
PhRMA
@PhRMA
Jun 7
Today is National Cancer Survivors Day, a time to celebrate life, honor resilience and look ahead at the incredible science bringing hope to millions. Hear from some of our companies on the future of cancer treatments and the investments being made to deliver new treatments and
00:00
716
PhRMA
@PhRMA
Jun 6
Cell and gene therapies are changing the future of medicine. But many Medicare patients still face barriers to accessing these innovative treatments. Our health care system must keep pace with innovation so patients can benefit from these breakthroughs.
Future of Medicine
From phrma.org
539
PhRMA
@PhRMA
Jun 6
Hospitals are converting to nonprofits to tap 340B revenue. This begs the question: is this massive federal program supporting patients or being exploited to boost hospital profits?
Private equity's new play? Become a nonprofit to profit off 340B.
From phrma.org
650
PhRMA
@PhRMA
Jun 5
June is Alzheimer’s & Brain Awareness Month — a time to recognize the millions of patients, families and caregivers impacted by Alzheimer’s disease and renew our commitment to advancing new treatments and cures. For decades, Alzheimer’s was considered one of medicine’s greatest
366
PhRMA
@PhRMA
Jun 5
As policymakers are considering harmful price control policies in the form of Most Favored Nation pricing, patients and caregivers are voicing their concerns. Hear what they have to say:
Patients Speak Out: MFN won't address my affordability concerns
From phrma.org
420
PhRMA
@PhRMA
Jun 4
On average, it takes 10 to 15 years and $2.6 billion to develop just one medicine, and only 12% of medicines entering clinical trials are successful in getting FDA approval. IP protections, including patents, empower innovators to take on significant risks to develop the best
624
PhRMA
@PhRMA
Jun 4
Two decades ago, it took 16 years on average for a new medicine to have two competitors — now it takes an average of just two years. The result — brand-to-brand competition — can lower the average cost of medicines by as much as 50%.
Sponsored Content: Fueling Innovation and Affordability in Health Care
From politico.com
421
PhRMA
@PhRMA
Jun 4
“Intellectual property doesn’t just protect ideas — it powers American jobs, strengthens local economies, and ensures the U.S. remains a global leader in innovation.” PhRMA general counsel, Jim Stansel, lays out the far reaching impact of IP for medicine advancement:
Behind Every Breakthrough: The IP System That Makes Medicine Possible
From notus.org
480
PhRMA
@PhRMA
Jun 3
Today, American patients enjoy access to more treatment options than anywhere else in the world. What do we have to thank for this success? Two legal foundations: our intellectual property system and the Hatch-Waxman Act passed in 1984.
00:00
Intellectual Property and Hatch-Waxman
From phrma.org
452